Introduction to 10X MitoScreen™
The 10X MitoScreen™, developed by 10X Health System in collaboration with Verséa Discovery, represents a significant advancement in mitochondrial assessment technology. This innovative test transforms advanced cellular analysis into actionable insights, focusing on enhancing energy, metabolism, and personalized performance.
What is MitoScreen™?
The 10X MitoScreen™ is an advanced mitochondrial health assessment tool that offers deeper insights into mitochondrial function and efficiency. With an emphasis on metabolic resilience, performance, and promoting long-term health, this assessment will soon be available for consumers and healthcare practitioners alike.
The Technology Behind 10X MitoScreen™
Grounded in pioneering research, the technology of 10X MitoScreen™ was first validated through the renowned NASA Twins Study. This critical study focused on understanding human performance, resilience, and recovery in extreme environments. Now, this technology allows for an unparalleled assessment of mitochondrial health that integrates biological visibility rarely seen in consumer health testing.
How 10X MitoScreen™ Works
The test utilizes a simple finger prick blood sample, analyzing key aspects of mitochondrial function and metabolic efficiency. Not only does it assess energy production, metabolic balance, and oxidative stress, but it also evaluates mitochondrial network dynamics, generating a unique integrated mitochondrial profile and score for users.
Understanding Your Results
Results from the 10X MitoScreen™ assessment provide vital insights into mitochondrial performance and adaptive capacity. This information can help establish personal baselines, track health changes over time, and inform comprehensive health optimization strategies as additional interpretive and protocol-based services become available.
Leveraging Insights for Better Health
Brandon Dawson, Co-Founder and CEO of 10X Health System, emphasizes the importance of this partnership with Verséa Discovery, stating, "Partnering with Verséa Discovery allows us to expand access to advanced biological insights that were once limited to research environments." This advancement provides individuals and practitioners with a detailed view of cellular activity, paving the way for more precise and proactive health management.
Vision for the Future
Sean Fetcho, Co-Founder and CEO of Verséa Discovery, shares insights on their commitment: "Built on years of research, our purpose is to bring measurable, trackable cellular and mitochondrial health to the world." The combined strengths of 10X Health and Verséa Discovery not only enhance personal health insights but also support the ongoing evolution of precision health.
Availability of 10X MitoScreen™
The 10X MitoScreen™ is set to launch in early 2026, expanding the precision testing portfolio of 10X Health System. Early access options are available for individuals eager to experience this cutting-edge assessment.
About 10X Health System
10X Health System is a pioneer in the precision wellness sector, dedicated to transforming how individuals understand and optimize their health. Utilizing advanced genetic testing and blood analysis, the company tailors its approach to uncover the root causes behind various health outcomes.
About Verséa Discovery
Verséa Discovery, Inc. is a leading precision medicine organization specializing in cellular and mitochondrial health technologies. With its proprietary mescreen™ technology validated through rigorous research, the company is advancing accessibility to next-generation health insights.
Frequently Asked Questions
What is the purpose of 10X MitoScreen™?
The 10X MitoScreen™ is designed to measure mitochondrial function and metabolism, helping individuals achieve optimized health through detailed insights.
How is the test conducted?
The test requires a simple finger prick blood sample, making it accessible and easy for individuals to undergo.
What are the potential benefits of the assessment?
By providing a comprehensive overview of mitochondrial health, users can track their health progress and make informed decisions about their wellness strategies.
When will 10X MitoScreen™ be available?
The launch of 10X MitoScreen™ is scheduled for early 2026, with early access options currently available.
Who can benefit from this assessment?
Both consumers and clinicians can benefit from the insights offered by the 10X MitoScreen™, facilitating personalized health optimization strategies.
